Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Trends in Pharmacological Sciences|July 6, 2010
Targeting homologous recombination repair defects in cancerBastiaan Evers, Thomas Helleday, Jos Jonkers
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Pooled shRNA Screening in Mammalian Cells as a Functional Genomic Discovery PlatformKatarzyna Jastrzebski, Bastiaan Evers, Roderick L Beijersbergen
Proteomes|March 3, 2017
Chronic Low Dose Rate Ionizing Radiation Exposure Induces Premature Senescence in Human Fibroblasts that Correlates with Up Regulation of Proteins Involved in Protection against Oxidative StressOlga Loseva, Emman Shubbar, Siamak Haghdoost, et al.
Nature Biotechnology|April 26, 2016
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genesBastiaan Evers, Katarzyna Jastrzebski, Jeroen P M Heijmans, et al.
Current Biology : CB|July 19, 2008
Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epitheliumAlexandra M Pietersen, Bastiaan Evers, Asheeta A Prasad, et al.
The Journal of Pathology|November 21, 2009
A tissue reconstitution model to study cancer cell-intrinsic and -extrinsic factors in mammary tumourigenesisBastiaan Evers, Ewoud N Speksnijder, Eva Schut, et al.
Cell Discovery|July 28, 2016
A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repairPatrick Herr, Cecilia Lundin, Bastiaan Evers, et al.
Journal of Hepatology|July 22, 2018
Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancerCun Wang, Haojie Jin, Dongmei Gao, et al.
Breast Cancer Research : BCR|August 28, 2009
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin AJulian Puppe, Rinske Drost, Xiaoling Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumorsBastiaan Evers, Eva Schut, Eline van der Burg, et al.
Pageof 3